Hepatocellular Cancer Symposium

26 June 2024

Hepatocellular Carcinoma (HCC) is a type of primary liver cancer that is also the most commonly-diagnosed liver cancer across the world. Join us for this important and informative discussion, where we will focus on the latest HCC updates and future directions of management.

Join a panel of experts who work across oncology, radiology and surgical practice, to explore a range of topics to identify existing and potential opportunities to change the liver cancer landscape here and overseas.

The discussion will focus on cutting-edge developments, promising treatments and novel approaches to this disease.

Key topics include:

• Epidemiology and screening

• Interventional radiology

• Surgery including transplantation

• Management strategies for advanced stages, including systemic and palliative therapies.

This symposium offers a unique opportunity to learn from leading experts, engage in meaningful discussions, and network with peers who share a passion for advancing the field of HCC management.

Aim:

To establish a common understanding and approach to treating hepatocellular cancer.

Learning Objectives:

• Explore the latest advancements and opportunities in the management of hepatocellular cancer, from screening and early detection to treatment of advanced stage disease.

• Identify and discuss the current variations in hepatocellular cancer care across Victoria, aiming to understand the underlying causes and implications for patient outcomes.

• Develop potential collaborations among healthcare providers, researchers, and policymakers with the goal of standardising and enhancing the multidisciplinary care for hepatocellular cancer patients. 

Hosts

Prof Peter Gibbs,
VCCC Alliance Research and Education Lead, Gastrointestinal Cancer

A/Prof Jessica Howell
Gastroenterologist and Senior Research Fellow, Department of Gastroenterology, St Vincent’s Hospital Melbourne and the University of Melbourne

Platinum Sponsors